Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DB25FKE55
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $279,264
Award facts
- Contract value 100% obligated
- $279,264.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 29, 2025, for GAMUNEX-C 40 gram/400 milliliter vials with a ceiling value of $279,264. The award is structured as a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle.
GAMUNEX-C is an immune globulin intravenous (human) product used to treat primary immunodeficiency and other immune-related conditions. This delivery order represents one of numerous pharmaceutical procurements through AmerisourceBergen's prime IDC with DLA, reflecting the company's critical role in supplying specialized medical commodities to support military healthcare programs and the Defense Health Agency. The contract demonstrates AmerisourceBergen's capability to meet federal medical procurement requirements through open competition and its ongoing partnership with DLA to maintain pharmaceutical supply chains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FKE55?
SPE2DB25FKE55 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FKE55 worth?
The government has obligated $279,264 on SPE2DB25FKE55.
Is contract SPE2DB25FKE55 an order under another contract?
Yes. SPE2DB25FKE55 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKE55 competed?
The extent of competition for SPE2DB25FKE55 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award